Fasting plasma glucose is an independent predictor of survival in patients with locally advanced non-small cell lung cancer treated with concurrent chemoradiotherapy

BMC Cancer
Milana BergaminoErnest Nadal

Abstract

Diabetes is related with increased cancer mortality across multiple cancer types. Its role in lung cancer mortality is still unclear. We aim to determine the prognostic value of fasting plasma glucose (FPG) and diabetes mellitus in patients with locally advanced non-small cell lung cancer (NSCLC) treated with concurrent chemoradiotherapy. One-hundred seventy patients with stage III NSCLC received definitive concurrent chemoradiotherapy from 2010 to 2014. Clinico-pathological data and clinical outcome was retrospectively registered. Fifty-six patients (33%), met criteria for type 2 diabetes mellitus (T2DM) at baseline. The prognostic value of FPG and other clinical variables was assessed. Overall survival (OS) and progression-free survival (PFS) were estimated using the Kaplan-Meier method and Cox proportional models and log-rank test were used. With a median follow-up of 36 months, median PFS was 8.0 months and median OS was 15.0 months in patients with FPG ≥7 mmol/L compared to 20 months (HR 1.13; 95% CI 1.07-1.19, p < 0.001) and 31 months (HR 1.09; 95% CI 1.04-1.15; p < 0.001) respectively, for patients with FPG < 7 mmol/L. In the multivariate analysis of the entire cohort adjusted by platinum compound and comorbidities, high...Continue Reading

References

Sep 30, 1993·The New England Journal of Medicine·UNKNOWN Diabetes Control and Complications Trial Research GroupC Siebert
Dec 18, 2008·JAMA : the Journal of the American Medical Association·Bethany B BaroneFrederick L Brancati
May 23, 2009·Science·Matthew G Vander HeidenCraig B Thompson
Jul 1, 2010·Diabetes Care·Edward GiovannucciDouglas Yee
Mar 4, 2011·The New England Journal of Medicine·Sreenivasa Rao Kondapally SeshasaiUNKNOWN Emerging Risk Factors Collaboration
Mar 8, 2011·Cell·Douglas Hanahan, Robert A Weinberg
Nov 25, 2011·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Juhua LuoLi-Jung Chang
May 17, 2012·World Journal of Radiology·Saeed MirsadraeeEdwin van Beek
Jun 19, 2014·Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al]·Arnulf MayerHeinz Schmidberger
Dec 19, 2014·American Journal of Respiratory and Critical Care Medicine·Jenny J LinJuan P Wisnivesky
Jan 6, 2015·BMJ : British Medical Journal·Konstantinos K TsilidisJohn P A Ioannidis
Dec 24, 2015·Diabetes Care·UNKNOWN American Diabetes Association
Feb 7, 2016·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Marliese AlexanderDavid Ball
Mar 6, 2016·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Stephanie C MelkonianXifeng Wu
May 20, 2016·British Journal of Cancer·Juhua LuoKaren L Margolis
Dec 3, 2016·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Gadi ShlomaiEmily Jane Gallagher
Apr 22, 2017·Critical Reviews in Oncology/hematology·Maaike C GerardsVictor E A Gerdes
May 10, 2017·Cancers·Michael Yousef, Evangelia Tsiani
May 24, 2017·Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists·Nina J KarlinCurtiss B Cook

❮ Previous
Next ❯

Citations

Oct 8, 2019·Annals of Thoracic and Cardiovascular Surgery : Official Journal of the Association of Thoracic and Cardiovascular Surgeons of Asia·Guoshu BiHong Fan
Jan 8, 2020·Nutrients·Maria CastejónAlberto Diaz-Ruiz
Apr 22, 2020·Proceedings of the National Academy of Sciences of the United States of America·Franziska PüschelCristina Muñoz-Pinedo
Jun 27, 2019·Seminars in Cell & Developmental Biology·Blanca MajemCristina Muñoz-Pinedo

❮ Previous
Next ❯

Software Mentioned

SPSS

Related Concepts

Related Feeds

Biomarkers for Type 2 Diabetes

Biomarkers can help understand chronic diseases and assist in risk prediction for prevention and early detection of diseases. Here is the latest research on biomarkers in type 2 diabetes, a disease in which the body is unable to produce or properly use insulin.